19.67 USD
↘ 0.17 (0.86%)AT CLOSE (03:59 PM EDT)
Assembly Biosciences, Inc
ASMBNASDAQ • USD
19.68
↗ 0.01 (0.03%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
19.68
↗ 0.01 (0.03%)
Market: CLOSED
ASMB is currently priced at $19.67. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. ASMB is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$19.97
High?$20.09
Low?$19.59
Prev. Close?$19.84
Volume?152.2K
Avg. Volume?313.5K
VWAP?$19.72
Rel. Volume?0.49x
Bid / Ask
Bid?$19.00 × 100
Ask?$19.96 × 1.0K
Spread?$0.96
Midpoint?$19.48
Valuation & Ratios
Market Cap?400.5M
Shares Out?20.4M
Float?10.4M
Float %?65.5%
P/E Ratio?N/A
P/B Ratio?1.31
EPS?-$0.00
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Employees
73
Market Cap
404.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2010-12-17
Address
TWO TOWER PLACE
SOUTH SAN FRANCISCO, CA 94080
Phone: (833) 409-4583
SOUTH SAN FRANCISCO, CA 94080
Phone: (833) 409-4583
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?100
Momentum?85
Short Sent.?10
Piotroski F-Score?3/9Weak
Altman Z-Score?7.21Safe
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?28.01%Squeeze Risk
Short Interest?2.9M
Days to Cover?11.1
Free Float10.4M
Avg Daily Volume263.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?13.99Strong
Quick Ratio?13.99Strong
Cash Ratio?1.38Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?1.31CHEAP▾
Peers100
S&P91
P/S?5.35FAIR▾
Peers100
S&P27
P/FCF?N/A▾
EV/EBITDA?-42.4CHEAP▾
S&P97
EV/Sales?4.92FAIR▾
Peers100
S&P37
Returns & Efficiency
ROE?-0.0%WEAK▾
S&P15
ROA?-0.0%WEAK▾
S&P8
Cash Flow & Enterprise
FCF?$-38566000
Enterprise Value?$368.2M
Fundamentals ratios updated end of day